Effective Treatment with Ronapreve 120mg Injection

Uses of Ronapreve 120mg Injection

• Treat and prevent acute COVID-19 infection.

Mechanism of Action

• Contains Casirivimab + Imdevimab, monoclonal antibodies.
• Attaches to the spike protein on the coronavirus surface.
• Blocks the receptor binding domain (RBD) to the ACE2 receptor.
• Prevents viral attachment to host cells.

Important Information

• Allergies: Do not take if allergic to Casirivimab + Imdevimab or other ingredients.
• Infusion Reactions: Notify your physician immediately if you face any infusion reactions.
• Pregnancy and Breastfeeding: Inform your doctor before initiating treatment.
• Vaccination: Inform your doctor if you have been vaccinated against COVID-19.
• Weight and Age: Recommended for individuals aged 12 years and older and weighing at least 35.5kg.

Side Effects

• Injection site reactions.
• Fever.
• Flushing.
• Shortness of breath.
• Chest tightness.
• Nausea.
• Vomiting.

Administration

• Given as an infusion into your vein (20-30 minutes) or as a subcutaneous injection.
• Administered by a doctor or nurse experienced in the use of this treatment.
• Do not self-administer.

Safety Advice

• Pregnancy: Limited information on safety during pregnancy.
• Breastfeeding: Limited information on safety during breastfeeding.
• Lungs: Consult your doctor if you have any lung diseases.
• Liver: Inform your physician if you have any liver problems.
• Alcohol: It is unknown whether it is safe to consume alcohol with Ronapreve 120mg Injection.
• Driving: Does not affect your ability to drive, but inform your physician if you face any symptoms that alter your concentration.

FAQs

1. How effective is Ronapreve 120mg Injection in treating COVID-19?

   • Clinical studies have shown that it can significantly reduce the risk of hospitalization or death in high-risk individuals with COVID-19.

2. Can Ronapreve 120mg Injection be used in combination with other COVID-19 treatments?

   • Yes, it can be used alone or in combination with other COVID-19 treatments as determined by healthcare professionals.

3. How soon after testing positive for COVID-19 should Ronapreve 120mg Injection be administered?

   • Ideally within 10 days of symptom onset.

4. Can Ronapreve 120mg Injection be used in pediatric patients?

   • Yes, authorized for use in pediatric patients aged 12 years and older who weigh at least 35.5kg and are at high risk of developing severe COVID-19.

5. Can Ronapreve 120mg Injection be used as a substitute for COVID-19 vaccination?

   • No, it is not a substitute for COVID-19 vaccination. Vaccination is the most effective way to prevent COVID-19 and its complications.

Storage

• Store in a refrigerator (2°C to 8°C).
• Do not freeze.
• Protect the medicine from light and excessive moisture.
• Keep out of reach of children and pets.
• If you missed the dosing schedule, inform your healthcare professional immediately and reschedule.

Fact Box

• Molecule name: Casirivimab + Imdevimab.
• Therapeutic class: Antiviral.
• Pharmacological class: Monoclonal Antibodies.
• Indications: Treat and prevent acute COVID-19 infection.

Tags: medical-injection, ronapreve, pharmaceuticals, 120mg, drug, healthcare, medicine